We tested for ALS-associated genetic variation within CAV1 and CAV2 exons by rare-variant burden testing using WGS data from 4,495 ALS cases and 1,925 controls (Project MinE; Data-Freeze-1). This evidence concerns the gene CAV1 and amyotrophic lateral sclerosis.